MARKET

NUVB

NUVB

Nuvation Bio Inc
NYSE
6.42
+0.05
+0.78%
After Hours: 6.40 -0.02 -0.29% 18:13 08/12 EDT
OPEN
6.42
PREV CLOSE
6.37
HIGH
6.48
LOW
6.32
VOLUME
2.59M
TURNOVER
--
52 WEEK HIGH
9.75
52 WEEK LOW
2.180
MARKET CAP
2.25B
P/E (TTM)
-14.7552
1D
5D
1M
3M
1Y
5Y
1D
Nuvation Bio Targets Post‑Vorasidenib Glioma With New Safusidenib Trial
TipRanks · 1d ago
Weekly Report: what happened at NUVB last week (0803-0807)?
Weekly Report · 2d ago
Nuvation Bio (NUVB) Stock Rises On IBTROZI Growth And Deeper Losses
Simply Wall St · 5d ago
Nuvation Bio Is Maintained at Outperform by RBC Capital
Dow Jones · 5d ago
Nuvation Bio Price Target Raised to $20.00/Share From $19.00 by RBC Capital
Dow Jones · 5d ago
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $20
Benzinga · 5d ago
Nuvation Bio price target raised to $14 from $12 at B. Riley
TipRanks · 5d ago
Why Nuvation Bio (NUVB) Is Down 8.8% After Surging Q2 2026 Revenue and IBTROZI Data Tease
Simply Wall St · 5d ago
More
About NUVB
Nuvation Bio Inc. is a global oncology company. The Company is focused on tackling cancer treatment. Its diverse pipeline includes taletrectinib (IBTROZI), a next-generation ROS1 inhibitor; safusidenib, a brain-penetrant IDH1 inhibitor, and a drug-drug conjugate (DDC) program. IBTROZI is an oral, potent, central nervous system-active, selective, next-generation ROS1 inhibitor. Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1), which is detected in various tumors, including gliomas. Its platform leverages its drug discovery and chemistry expertise to find the minimum target binding sites of drug X and drug Y and fuse them together, while maintaining activity. Its DDCs are designed to selectively bind to intracellular as well as surface cell membrane targets that are expressed more highly in specific target tissues and to potently deliver anti-cancer warheads to these target tissues.

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB stock methods without spending real money on the virtual paper trading platform.